Unlocking the power of precision medicine for pediatric low-grade gliomas: molecular characterization for targeted therapies with enhanced safety and efficacy

In the past decade significant advancements have been made in the discovery of targetable lesions in pediatric low-grade gliomas (pLGGs). These tumors account for 30-50% of all pediatric brain tumors with generally a favorable prognosis. The latest 2021 WHO classification of pLGGs places a strong em...

Descripción completa

Detalles Bibliográficos
Autores principales: Cipri, Selene, Del Baldo, Giada, Fabozzi, Francesco, Boccuto, Luigi, Carai, Andrea, Mastronuzzi, Angela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311254/
https://www.ncbi.nlm.nih.gov/pubmed/37397394
http://dx.doi.org/10.3389/fonc.2023.1204829

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10311254/
https://www.ncbi.nlm.nih.gov/pubmed/37397394
http://dx.doi.org/10.3389/fonc.2023.1204829

Ejemplares similares